O-007 Neuropilin 1 (NRP1) may be prognostic and identify a subgroup of Patients with Metastatic Colorectal Cancer (mCRC) who Benefit from Tivozanib + mFOLFOX6 compared to Bevacizumab + mFOLFOX6
| Autor: | Benson, A., Krivoshik, A., Van Sant, C., Needle, M. |
|---|---|
| Zdroj: | In Annals of Oncology June 2015 26 Supplement 4:iv109-iv109 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|